| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684573 | Experimental Neurology | 2018 | 4 Pages |
Abstract
This simple monitoring approach based on serum NfL concentration measures may be easily translated to clinical practice and should be considered as a putative marker of CIPN severity in a typical oncology outpatient setting. Further studies are needed to validate its utility in cancer patients treated with different neurotoxic drugs.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Cristina Meregalli, Giulia Fumagalli, Paola Alberti, Annalisa Canta, Valentina Alda Carozzi, Alessia Chiorazzi, Laura Monza, Eleonora Pozzi, Ã
sa Sandelius, Kaj Blennow, Henrik Zetterberg, Paola Marmiroli, Guido Cavaletti,